CN Stock MarketDetailed Quotes

603233 DaShenLin Pharmaceutical Group

Watchlist
  • 14.18
  • +0.08+0.57%
Market Closed Jul 5 15:00 CST
16.15BMarket Cap15.12P/E (TTM)

DaShenLin Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

DaShenLin Pharmaceutical Group Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

6.75B

+13.54%
EPS(YoY)

0.35

-32.69%
Analyst Rating

Strong Buy

Jul 6, 2024

DaShenLin Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 7.275B--
Aug 31, 20242024/Q2-- / 7.220B--
--2024/Q16.752B / 6.842B--
--2023/Q46.808B / 6.760B--
--2023/Q35.731B / 6.269B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 7.275B--
Aug 31, 20242024/Q2-- / 7.220B--
--2024/Q16.752B / 6.842B--
--2023/Q46.808B / 6.760B--
--2023/Q35.731B / 6.269B--

Unlock Free Earnings Estimates

DaShenLin Pharmaceutical Group Earnings Reports

  • Summary of the 2023 Annual Report of Dashenlin Pharmaceutical Group Co., Ltd.

    Apr 28 12:00 ET

  • Dashenlin Pharmaceutical Group Co., Ltd. 2023 Annual Report

    Apr 28 12:00 ET

  • Dashenlin Pharmaceutical Group Co., Ltd. Report for the first quarter of 2024

    Apr 28 12:00 ET

  • Dashenlin Pharmaceutical Group Co., Ltd. 2023 Third Quarter Report

    Oct 30, 2023 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 6, 2024

    Strong Buy

    • Strong Buy

      82.61%

    • Buy

      17.39%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg